Refractory Colorectal Adenocarcinoma
5 clinical trials · Condition
◉ Watch Refractory Colorectal Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Rintatolimod and Pembrolizumab for the Treatment of Refractory Metastatic or Unresectable Colorectal Cancer (NCT04119830) | Roswell Park Cancer Institute | 2022-02-01 |
| caBozantinib in Pre-treated pAtients With Metastatic COlorectal Cancer. (NCT06171854) | University of Campania Luigi Vanvitelli | 2019-09-01 |
| Panitumumab With or Without Trametinib in Treating Patients With Stage IV Colorectal Cancer (NCT03087071) | M.D. Anderson Cancer Center | 2017-12-29 |
Track Refractory Colorectal Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.